Drugs / LTI-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04159831 | Sep 2020 → Mar 2022 | pleural empyema | Rein Therapeutics | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LTI-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04159831 ↗ |
| Route | Other | “administered intrapleurally once daily for up to 3 days” PMID 42310706 ↗ Jun 2026 |